13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q2 2020. See the latest, Q3 2026 →
Reported value
$8.01B
+18% on the quarter before
Positions
31
4 new, 6 sold out
Top 10
76.0%
of the value
Est. gain
+$2.05B
on stocks held all quarter
Est. return
+35.8%
on those stocks since Q1 2020
Positions as of Jun 30, 2020, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2020. Striped tiles are options.
Largest buys
Since Q1 2020, sized at quarter-end prices.
- Hca Healthcare Inc~$97.1MNew, 0.0% → 1.2% of the portfolio+1,000,000 shares
- Verint Sys Inc~$27.8MNew, 0.0% → 0.3% of the portfolio+616,328 shares
- Atara Biotherapeutics Inc~$23.5MAdded, 1.0% → 1.8% of the portfolio+1,613,130 shares
- Ventas Inc~$20.1MNew, 0.0% → 0.3% of the portfolio+550,000 shares
- Liberty Global Plc~$18.3MAdded, 12.5% → 14.6% of the portfolio+850,000 shares
- Hd Supply Hldgs Inc~$14.0MAdded, 2.6% → 2.9% of the portfolio+403,653 shares
- Translate Bio Inc~$8.8MAdded, 2.5% → 4.0% of the portfolio+500,000 shares
- Ss&C Technologies Hldgs Inc~$7.9MNew, 0.0% → 0.1% of the portfolio+140,516 shares
- Qorvo~$287,378Added, 3.6% → 4.2% of the portfolio+2,600 shares
Largest sells
Since Q1 2020, sized at quarter-end prices.
- Cheniere Energy Inc~$272.2MSold out, 4.0% → 0.0% of the portfolio−8,124,235 shares
- Meta~$257.2MCut, 4.9% → 2.4% of the portfolio−1,132,500 shares
- Alphabet~$121.3MCut, 5.2% → 3.8% of the portfolio−85,820 shares
- Viacomcbs Inc~$85.4MCut, 4.7% → 5.5% of the portfolio−3,662,415 shares
- Univar Solutions Inc~$71.1MCut, 0.9% → 0.3% of the portfolio−4,216,752 shares
- Colony Cap Inc New~$57.6MCut, 1.3% → 0.8% of the portfolio−24,000,000 shares
- Energy Transfer Lp~$55.7MSold out, 0.8% → 0.0% of the portfolio−12,105,005 shares
- Amerisourcebergen Corp~$47.2MCut, 1.2% → 0.6% of the portfolio−468,149 shares
- Pg&E Corp~$44.4MCut, 1.3% → 0.5% of the portfolio−5,000,000 shares
- Xpo Logistics Inc~$41.2MSold out, 0.6% → 0.0% of the portfolio−845,877 shares
Holdings
As of Jun 30, 2020; changes in shares since Mar 31, 2020.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Ebay Inc.COM · shares 0% · price +74.5% | 21.0% | $1.68B | +$718.4M | ||||||
| Liberty Global PlcSHS CL C · shares +1.6% · price +36.9% | 14.6% | $1.17B | +$311.5M | ||||||
| Fox CorpCL A COM · shares 0% · price +13.5% | 9.1% | $732.8M | +$87.2M | ||||||
| Viasat IncCOM · shares 0% · price +6.8% | 6.6% | $526.9M | +$33.6M | ||||||
| Viacomcbs IncCL B · shares −16% · price +66.5% | 5.5% | $439.3M | +$175.4M | ||||||
| QorvoCOM · shares +0.08% · price +37.1% | 4.2% | $338.8M | +$91.6M | ||||||
| Translate Bio IncCOM · shares +2.8% · price +81.4% | 4.0% | $319.1M | +$139.2M | ||||||
| Hp IncCOM · shares −10.0% · price +0.4% | 3.9% | $313.8M | +$1.3M | ||||||
| AlphabetCAP STK CL C · shares −29% · price +21.6% | 3.8% | $303.5M | +$53.8M | ||||||
| Mckesson CorpCOM · shares 0% · price +13.4% | 3.2% | $256.1M | +$30.3M | ||||||
| Hd Supply Hldgs IncCOM · shares +6.5% · price +21.9% | 2.9% | $229.4M | +$38.7M | ||||||
| Akebia Therapeutics IncCOM · shares −14% · price +79.2% | 2.5% | $203.7M | +$90.0M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price −9.2% | 2.4% | $195.4M | −$19.7M | ||||||
| MetaCL A · shares −57% · price +36.1% | 2.4% | $193.3M | +$51.3M | ||||||
| Nexstar Media Group IncCL A · shares 0% · price +45.0% | 2.2% | $174.5M | +$54.1M | ||||||
| Liberty Global PlcSHS CL A · shares 0% · price +32.4% | 2.1% | $167.4M | +$41.0M | ||||||
| Fox CorpCL B COM · shares 0% · price +17.3% | 1.9% | $152.5M | +$22.5M | ||||||
| Atara Biotherapeutics IncCOM · shares +19% · price +71.2% | 1.8% | $144.6M | +$50.4M | ||||||
| Hca Healthcare IncCOM · shares New | 1.2% | $97.1M | — | ||||||
| Colony Cap Inc NewCL A COM · shares −48% · price +37.1% | 0.77% | $61.6M | +$16.7M | ||||||
| Veritiv CorpCOM · shares 0% · price +115.8% | 0.75% | $60.5M | +$32.4M | ||||||
| Amerisourcebergen CorpCOM · shares −50% · price +13.9% | 0.59% | $47.2M | +$5.7M | ||||||
| Pg&E CorpCOM · shares −52% · price −1.3% | 0.52% | $41.7M | −$563,981 | ||||||
| Theravance Biopharma IncNOTE 3.250%11/0 · shares 0% · price +1.7% | 0.36% | $29.2M | — | ||||||
| Verint Sys IncCOM · shares New | 0.35% | $27.8M | — | ||||||
| Total 31 positions | 100% | $8.01B | +$2.05B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2020 to Q2 2020: 26 stocks held throughout, up $2.05B (+35.8%).
- Ebay Inc.+$718.4M+74%
- Liberty Global Plc+$311.5M+37%
- Viacomcbs Inc+$175.4M+66%
- Translate Bio Inc+$139.2M+81%
- Qorvo+$91.6M+37%
- Pg&E Corp−$563,981−1%
- Theravance Biopharma Inc−$19.7M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |